Trials / Recruiting
RecruitingNCT05881226
Application of Biomarkers in Neurological Diseases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Yi Yang · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
To explore the predictive and diagnostic role of biomarkers in patients with neurological diseases.
Detailed description
With the rise and continuous development of omics technology and bioinformatics technology, some scholars have applied proteomics technology and metabolomics technology to study the brain tissue, plasma and CSF of patients with nervous system diseases, so as to screen out potential biomarkers, with a view to providing new research ideas for pathogenesis and early diagnosis of neurological diseases. At present, the research on some novel biomarkers is still in its infancy, and many key problems remain to be solved. It is necessary to further determine the expression level of biomarkers in normal human body and the characteristics of biomarkers in patients with neurological diseases.
Conditions
Timeline
- Start date
- 2023-06-05
- Primary completion
- 2030-12-01
- Completion
- 2031-12-01
- First posted
- 2023-05-31
- Last updated
- 2024-03-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05881226. Inclusion in this directory is not an endorsement.